ResearcherPhilipps University of MarburgActive in the last 2 years

Philipp Lishewski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-3878-6984; OpenAlex author ID A5114301390. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outcome. Co-author DOI 10.3389/fonc.2026.1710943 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ahmed Gawish · 1 shared paper, 2026 · strength 0.26
- Paper Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outc… DOI 10.3389/fonc.2026.1710943 ↗
Fabian Eberle · 1 shared paper, 2026 · strength 0.26
- Paper Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outc… DOI 10.3389/fonc.2026.1710943 ↗
Thomas Held · 1 shared paper, 2026 · strength 0.26
- Paper Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outc… DOI 10.3389/fonc.2026.1710943 ↗
Daniel Habermehl · 1 shared paper, 2026 · strength 0.26
- Paper Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outc… DOI 10.3389/fonc.2026.1710943 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.